An Open-Label Study Using the Medpulser Electroporation System to Treat Head and Neck Cancer.

Trial Profile

An Open-Label Study Using the Medpulser Electroporation System to Treat Head and Neck Cancer.

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Sep 2012

At a glance

  • Drugs Bleomycin (Primary)
  • Indications Head and neck cancer
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 23 Apr 2012 Interim results from 81 patients have been presented at the 5th European Conference on Head and Neck Oncology according to an OncoSec Medical media release.
    • 26 Sep 2011 Primary endpoint 'Locoregional-control' has been met, as reported in an OncoSec Medical media release.
    • 26 Sep 2011 Positive interim results reported in an OncoSec Medical media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top